{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:05:24Z","timestamp":1773234324705,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10633-015-9494-x","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T05:51:05Z","timestamp":1426744265000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features"],"prefix":"10.1007","volume":"131","author":[{"given":"C\u00e9line","family":"Faure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Audo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Bernard","family":"Letessier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu P.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"9494_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bjo.56.2.131","volume":"56","author":"ME Cameron","year":"1972","unstructured":"Cameron ME, Lawrence JM, Olrich JG (1972) Thioridazine (Melleril) retinopathy. Br J Ophthalmol 56:131\u2013134","journal-title":"Br J Ophthalmol"},{"key":"9494_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archopht.1960.01840010067005","volume":"64","author":"RD Weekley","year":"1960","unstructured":"Weekley RD, Potts AM, Reboton J, May RH (1960) Pigmentary retinopathy in patients receiving high doses of a new phenothiazine. Arch Ophthalmol 64:95\u2013106","journal-title":"Arch Ophthalmol"},{"key":"9494_CR3","first-page":"737","volume":"132","author":"RW Lam","year":"1985","unstructured":"Lam RW, Remick RA (1985) Pigmentary retinopathy associated with low-dose thioridazine treatment. Can Med Assoc J 132:737","journal-title":"Can Med Assoc J"},{"key":"9494_CR4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/ajp.143.2.256","volume":"143","author":"WA Ball","year":"1986","unstructured":"Ball WA, Caroff SN (1986) Retinopathy, tardive dyskinesia, and low-dose thioridazine. Am J Psychiatry 143:256\u2013257","journal-title":"Am J Psychiatry"},{"key":"9494_CR5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/eye.1990.112","volume":"4","author":"MS Neves","year":"1990","unstructured":"Neves MS, Jordan K, Dragt H (1990) Extensive chorioretinopathy associated with very low dose thioridazine. Eye (Lond) 4:767\u2013770","journal-title":"Eye (Lond)"},{"key":"9494_CR6","first-page":"1234","volume":"153","author":"JL Tekell","year":"1996","unstructured":"Tekell JL, Silva JA, Maas JA, Bowden CL, Starck T (1996) Thioridazine-induced retinopathy. Am J Psychiatry 153:1234\u20131235","journal-title":"Am J Psychiatry"},{"key":"9494_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1442-9071.2003.00716.x","volume":"31","author":"PW Hadden","year":"2003","unstructured":"Hadden PW, Tay-Kearney ML, Barry CJ, Constable IJ (2003) Thioridazine retinopathy. Clin Exp Ophtalmol 31:533\u2013534","journal-title":"Clin Exp Ophtalmol"},{"key":"9494_CR8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archopht.120.7.994","volume":"120","author":"N Borodoker","year":"2002","unstructured":"Borodoker N, Del Priore LV, De A, Carvalho C, Yanuzzi LA (2002) Retinopathy as a result of long-term use of thioridazine. Arch Ophthalmol 120:994\u2013995","journal-title":"Arch Ophthalmol"},{"key":"9494_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00006982-198400440-00008","volume":"4","author":"D Kozy","year":"1984","unstructured":"Kozy D, Doft BH, Lipkowitz J (1984) Nummular thioridazine retinopathy. Retina 4:253\u2013256","journal-title":"Retina"},{"key":"9494_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/112067210601600430","volume":"16","author":"IA Chaudhry","year":"2006","unstructured":"Chaudhry IA, Shamsi PA, Weitzmann ML (2006) Progressive severe visual loss after long-term withdrawal from thioridazine treatment. Eur J Ophthalmol 16:651\u2013653","journal-title":"Eur J Ophthalmol"},{"key":"9494_CR11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/bjo.74.12.739","volume":"74","author":"MF Marmor","year":"1990","unstructured":"Marmor MF (1990) Is thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function. Br J Ophtalmol 74:739\u2013742","journal-title":"Br J Ophtalmol"},{"key":"9494_CR12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1192\/bjp.166.6.822b","volume":"166","author":"AC Mitchell","year":"1995","unstructured":"Mitchell AC, Brown KW (1995) Chlorpromazine-induced retinopathy. Br J Psychiatry 166:822\u2013823","journal-title":"Br J Psychiatry"},{"key":"9494_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000078784","volume":"36","author":"MS Lee","year":"2004","unstructured":"Lee MS, Fern AI (2004) Fluphenazine and its toxic maculopathy. Ophthalmic Res 36:237\u2013239","journal-title":"Ophthalmic Res"},{"key":"9494_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jop.2005.21.259","volume":"21","author":"SM Toler","year":"2005","unstructured":"Toler SM (2005) Invited review: fluphenazine arguments retinal oxidative stress. J Ocul Pharmacol Ther 21:259\u2013265","journal-title":"J Ocul Pharmacol Ther"},{"key":"9494_CR15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5694\/j.1326-5377.2009.tb02353.x","volume":"190","author":"AM Borovik","year":"2009","unstructured":"Borovik AM, Bosch MM, Watson SL (2009) Ocular pigmentation associated with clozapine. Med J Aust 190:210\u2013211","journal-title":"Med J Aust"},{"key":"9494_CR16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00417-012-2071-z","volume":"251","author":"K Manousardis","year":"2013","unstructured":"Manousardis K, Gupta R (2013) Risperidone-related bilateral cystoid macular oedema. Graefes Arch Clin Exp Ophthalmol 251:1037\u20131038","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9494_CR17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2133\/dmpk.22.358","volume":"22","author":"M Kubo","year":"2007","unstructured":"Kubo M, Koue T, Maune H, Fukufa T, Azuma J (2007) Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism. Drug Metab Pharmacokinet 22:358\u2013366","journal-title":"Drug Metab Pharmacokinet"},{"key":"9494_CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/15569527.2011.603106","volume":"31","author":"AG Nair","year":"2012","unstructured":"Nair AG, Nair AG, George RJ, Biswas J, Gandhi RA (2012) Aripiprazole induced transient myopia: a case report and review of literature. Cutan Ocul Toxicol 31:74\u201376","journal-title":"Cutan Ocul Toxicol"},{"key":"9494_CR19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0161-6420(82)34613-8","volume":"89","author":"FS Miller","year":"1982","unstructured":"Miller FS, Bunt-Milan AH, Kalina RE (1982) Clinical-ultrastructural study of thioridazine retinopathy. Ophthalmology 89:1478\u20131486","journal-title":"Ophthalmology"},{"key":"9494_CR20","first-page":"293","volume":"22","author":"V Godel","year":"1990","unstructured":"Godel V, Loewenstein A, Lazar M (1990) Spectral electroretinography in thioridazine toxicity. Ann Ophthalmol 22:293\u2013296","journal-title":"Ann Ophthalmol"},{"key":"9494_CR21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/archopht.116.6.826","volume":"116","author":"GK Shah","year":"1998","unstructured":"Shah GK, Auerbach DB, Augsburger JJ, Savino PJ (1998) Acute thioridazine retinopathy. Arch Ophthalmol 116:826\u2013827","journal-title":"Arch Ophthalmol"},{"key":"9494_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1015768114192","volume":"105","author":"P Fornaro","year":"2002","unstructured":"Fornaro P, Calabria G, Corallo G, Picotti GB (2002) Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis. Doc Ophthalmol 105:41\u201349","journal-title":"Doc Ophthalmol"},{"key":"9494_CR23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:DOOP.0000019487.88486.0a","volume":"108","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky P (2004) Dopamine and retinal function. Doc Ophthalmol 108:17\u201340","journal-title":"Doc Ophthalmol"},{"key":"9494_CR24","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/IAE.0b013e318296b12f","volume":"33","author":"NR Goldberg","year":"2013","unstructured":"Goldberg NR, Greenberg JP, Laud K, Tsang S, Freund KB (2013) Outer retinal tubulation in degenerative retinal disorders. Retina. 33:1871\u20131876","journal-title":"Retina."}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-015-9494-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-015-9494-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-015-9494-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:49:24Z","timestamp":1598834964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-015-9494-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["9494"],"URL":"https:\/\/doi.org\/10.1007\/s10633-015-9494-x","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}